Livedoid Vasculopathy: Strong Association With Smoking, Weak Association With Thrombophilia

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

15 participants

Study Classification

OBSERVATIONAL

Study Start Date

2013-08-31

Study Completion Date

2015-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A screening of patient histories at the clinics of Dermatology of the universities of Zurich, Basel and Bern is performed in order to identify patients with a history of Livedoid vasculopathy. Patients with a history of livedoid vasculopathy are asked to participate in the study. After reading the patient information and if the informed consent is signed patients are included in the study. Patients are questioned about their smoking history and blood is drawn in order to perform a screening for thrombophilia.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Prevalence of Onychodystrophy in Patients With Chronic Venous Disease of the Lower Limbs

NCT02731222

Lower Extremity Chronic Venous Insufficiency Onychodystrophy

COMPLETED

Genetic Architecture of Neutrophil-Mediated Inflammatory Skin Diseases

NCT05732987

Neutrophil-mediated Inflammatory Dermatoses Inflammatory Dermatoses

RECRUITING

Optical Coherence Tomography Imaging in Systemic Sclerosis

NCT04532151

Systemic Sclerosis Early Systemic Sclerosis Without Clinical Scleroderma and Onset < 2 Years

COMPLETED NA

Pathogenic Mechanisms Involved in the Initiation and Progression of Systemic Sclerosis

NCT07015060

Scleroderma (Limited and Diffuse)

NOT_YET_RECRUITING NA

Endothelial Biomarkers of Systemic Sclerosis-associated Pulmonary Hypertension

NCT03459716

Scleroderma Pulmonary Hypertension

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A screening of patient histories at the clinics of Dermatology of the universities of Zurich, Basel and Bern is performed in order to identify patients with a history of Livedoid vasculopathy. Patients with a history of livedoid vasculopathy are asked to participate in the study. The presence of Livedoid vasculopathy must be confirmed by a histologic specimen. After reading the patient information and if the informed consent is signed patients are included in the study. Patients are questioned about their smoking history and blood is drawn in order to perform a screening for thrombophilia. The presence of a history of smoking and thrombophilia is compared to the general Swiss population.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Livedoid Vasculitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Thrombophilia screening

Patients with livedoid vasculopathy. Investigated by thrombophilia screening

Thrombophilia screening

Intervention Type OTHER

No intervention. Blood is drawn for analysis.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Thrombophilia screening

No intervention. Blood is drawn for analysis.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* History of livedoid vasculopathy

Exclusion Criteria

* Diagnosis was not proved by biopsy specimen
* A different reason than livedoid vasculopathy has been found for the symptoms of the patient
* No informed consent by the patient

Minimum Eligible Age

10 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No